Congenital toxoplasmosis: value of prenatal treatment with pyrimethamine-sulfadoxine combination.
I
I
Villena
C
C
Quereux
J M
JM
Pinon
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D005260:Female; D005315:Fetal Diseases / Q000188:drug therapy*; D006801:Humans; D011247:Pregnancy; D011739:Pyrimethamine / Q000627:therapeutic use*; D013413:Sulfadoxine / Q000627:therapeutic use*; D014125:Toxoplasmosis, Congenital / Q000175:diagnosis / Q000188:drug therapy*
D000890:Anti-Infective Agents; D000981:Antiprotozoal Agents; D013413:Sulfadoxine; D011739:Pyrimethamine